Anthony J. Bench

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

E. Joanna Baxter, Linda M. Scott, Peter J. Campbell et al. · The Lancet · 2005 · 3.4K citations

Hematological Malignancy, Acquired Mutation, Receptor Tyrosine Kinase +9

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

E. Joanna Baxter, Linda M. Scott, Peter J. Campbell et al. · The Lancet · 2005 · 1.1K citations

Hematological Malignancy, Acquired Mutation, Receptor Tyrosine Kinase +9

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study

Peter J. Campbell, Linda M. Scott, Georgina Buck et al. · The Lancet · 2005 · 643 citations

Thrombopoiesis, Immunohematology, Thrombosis +10

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort

Philip Beer, Peter J. Campbell, Linda M. Scott et al. · Blood · 2008 · 419 citations · Full text

Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia

Paul Sinclair, Elisabeth P. Nacheva, M. Leversha et al. · Blood · 2000 · 308 citations